Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Inflamm Bowel Dis. 2016 Jan;22(1):224–233. doi: 10.1097/MIB.0000000000000589

Table 4.

Detectable infliximab (IFX), IFX trough levels and detectable anti-IFX antibodies in the COMMIT study (n=126 patients).60

Detectable IFX p-value IFX trough- level (mg/ml) p-value Detectable IFX Antibody p-value
IFX+MTX 20% <0.08 6.4 <0.08 4% <0.01
IFX 14% 3.8 20%